{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:44:19Z","timestamp":1792179859783,"version":"4.4.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012610","name":"Victorian Lions Foundation Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011779","name":"Brien Holden Vision Institute Limited","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011779","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ajo.2025.06.034","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T11:47:59Z","timestamp":1750420079000},"page":"212-221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Factors Affecting the Lifetime Cost of Myopia and the Impact of Active Myopia Treatments in Europe"],"prefix":"10.1016","volume":"278","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0908-7280","authenticated-orcid":false,"given":"Ling","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4082-3759","authenticated-orcid":false,"given":"Laura","family":"De Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Barclay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Tahhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9289-5731","authenticated-orcid":false,"given":"Kathryn","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6180-418X","authenticated-orcid":false,"given":"Emma","family":"McConnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9171-3070","authenticated-orcid":false,"given":"Neema","family":"Ghorbani-Mojarrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annegret","family":"Dahlmann-Noor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Jaselsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8533-9457","authenticated-orcid":false,"given":"Nicolas","family":"Leveziel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Bremond-Gignac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5866-4446","authenticated-orcid":false,"given":"Serge","family":"Resnikoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8087-6835","authenticated-orcid":false,"given":"Timothy R.","family":"Fricke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2025.06.034_bib0001","unstructured":"World Health Organization. World report on vision. 2019. Accessed March 15, 2024. https:\/\/www.who.int\/publications\/i\/item\/world-report-on-vision."},{"key":"10.1016\/j.ajo.2025.06.034_bib0002","series-title":"Updates on myopia: a clinical perspective","first-page":"27","article-title":"Global epidemiology of myopia","author":"Matsumura","year":"2020"},{"issue":"5","key":"10.1016\/j.ajo.2025.06.034_bib0003","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1167\/iovs.62.5.6","article-title":"IMI Prevention of myopia and its progression","volume":"62","author":"Jonas","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2025.06.034_bib0004","article-title":"Global prevalence, trend and projection of myopia in children and adolescents from 1990 to 2050: a comprehensive systematic review and meta-analysis","author":"Liang","year":"2024","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.06.034_bib0005","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1177\/1120672121998960","article-title":"Update and guidance on management of myopia. European Society of Ophthalmology in cooperation with International Myopia Institute","volume":"31","author":"Nemeth","year":"2021","journal-title":"Eur J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2025.06.034_bib0006","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/iovs.62.5.2","article-title":"IMI impact of myopia","volume":"62","author":"Sankaridurg","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.ajo.2025.06.034_bib0007","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1167\/iovs.61.4.49","article-title":"The complications of myopia: a review and meta-analysis","volume":"61","author":"Haarman","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.ajo.2025.06.034_bib0008","doi-asserted-by":"crossref","first-page":"M106","DOI":"10.1167\/iovs.18-25958","article-title":"IMI\u2014Interventions Myopia Institute: interventions for controlling myopia onset and progression report","volume":"60","author":"Wildsoet","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.ajo.2025.06.034_bib0009","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1136\/bjophthalmol-2021-320318","article-title":"Establishing a method to estimate the effect of antimyopia management options on lifetime cost of myopia","volume":"107","author":"Fricke","year":"2023","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.06.034_bib0010","doi-asserted-by":"crossref","first-page":"M184","DOI":"10.1167\/iovs.18-25977","article-title":"IMI\u2014Clinical management guidelines report","volume":"60","author":"Gifford","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2025.06.034_bib0011","unstructured":"World Health Organization. WHO methods and data sources for global burden of disease estimates 2000-2019. World Health Organization; 2020. Accessed March 15, 2024. https:\/\/www.who.int\/docs\/default-source\/gho-documents\/global-health-estimates\/ghe2019_daly-methods.pdf."},{"key":"10.1016\/j.ajo.2025.06.034_bib0012","unstructured":"Board of Governors of the Federal Reserve System. Foreign Exchange Rates\u2014H.10. US Federal Reserve. Updated April 10th. Accessed April 22, 2024. https:\/\/www.federalreserve.gov\/releases\/h10\/current\/."},{"issue":"5","key":"10.1016\/j.ajo.2025.06.034_bib0013","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/bjophthalmol-2020-316880","article-title":"Health economic evaluation in ophthalmology","volume":"105","author":"Atik","year":"2021","journal-title":"Br J Ophthalmol"},{"issue":"15","key":"10.1016\/j.ajo.2025.06.034_bib0014","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/jama.1996.03540150055031","article-title":"Recommendations of the Panel on Cost-effectiveness in Health and Medicine","volume":"276","author":"Weinstein","year":"1996","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ajo.2025.06.034_bib0015","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/eye.2013.256","article-title":"Myopia, an underrated global challenge to vision: where the current data takes us on myopia control","volume":"28","author":"Holden","year":"2014","journal-title":"Eye"},{"issue":"6","key":"10.1016\/j.ajo.2025.06.034_bib0016","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/iovs.64.6.2","article-title":"IMI\u2014onset and progression of myopia in young adults","volume":"64","author":"Bullimore","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.ajo.2025.06.034_bib0017","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1136\/bjophthalmol-2020-316234","article-title":"Myopia progression from wearing first glasses to adult age: the DREAM Study","volume":"106","author":"Polling","year":"2022","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2025.06.034_bib0018","doi-asserted-by":"crossref","DOI":"10.1167\/iovs.62.5.7","article-title":"IMI 2021 yearly digest","volume":"62","author":"Jong","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.ajo.2025.06.034_bib0019","doi-asserted-by":"crossref","DOI":"10.1167\/iovs.64.6.7","article-title":"IMI 2023 digest","volume":"64","author":"Sankaridurg","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2025.06.034_bib0020","unstructured":"Ulster University. Predicting Myopia Onset and progression (PreMO): an evidence-based risk indicator for eye care practitioners Updated March 2024. Accessed March 22, 2024. https:\/\/www.ulster.ac.uk\/_data\/assets\/pdf_file\/0011\/826184\/PreMO-risk-indicator-for-website.pdf."},{"key":"10.1016\/j.ajo.2025.06.034_bib0021","unstructured":"The College of Optometrists. Guidance for Professional Practice. Updated 2024. Accessed March, 2024. https:\/\/www.college-optometrists.org\/clinical-guidance\/guidance."},{"key":"10.1016\/j.ajo.2025.06.034_bib0022","unstructured":"Office for National Statistics. National life tables. 11 January 2024. Accessed 12 April 2024. https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/birthsdeathsandmarriages\/lifeexpectancies."},{"key":"10.1016\/j.ajo.2025.06.034_bib0023","unstructured":"OECD. Life expectancy at 65. Accessed March 22, 2024. https:\/\/www.oecd-ilibrary.org\/content\/data\/0e9a3f00-en."},{"key":"10.1016\/j.ajo.2025.06.034_bib0024","unstructured":"White N. Low and high pay in the UK: 2023. Office for National Statistics (ONS). Accessed April 16, 2024. https:\/\/www.ons.gov.uk\/employmentandlabourmarket\/peopleinwork\/earningsandworkinghours\/bulletins\/lowandhighpayuk\/2023#glossary%20(accessed%2013\/2\/24."},{"key":"10.1016\/j.ajo.2025.06.034_bib0025","unstructured":"Ministry of Labor and Employment (France). Interprofessional minimum growth wage (SMIC) annual data from 1980 to 2024. Accessed April 2024. https:\/\/www.insee.fr\/fr\/statistiques\/1375188."},{"key":"10.1016\/j.ajo.2025.06.034_bib0026","unstructured":"CDC\/National Center for Health Statistics. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey (NHaNES). Accessed August 18, 2022. https:\/\/wwwn.cdc.gov\/nchs\/nhanes\/Search\/default.aspx."},{"issue":"1","key":"10.1016\/j.ajo.2025.06.034_bib0027","doi-asserted-by":"crossref","first-page":"6366","DOI":"10.1038\/s41598-021-85617-4","article-title":"Myopia, corneal endothelial cell density and morphology in a Japanese population-based cross-sectional study: the JPHC-NEXT Eye Study","volume":"11","author":"Aketa","year":"2021","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.ajo.2025.06.034_bib0028","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/jech-2013-203265","article-title":"Area deprivation, individual socioeconomic status and low vision in the EPIC-Norfolk Eye Study","volume":"68","author":"Yip","year":"2014","journal-title":"J Epidemiol Community Health"},{"issue":"6","key":"10.1016\/j.ajo.2025.06.034_bib0029","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1167\/iovs.64.6.6","article-title":"IMI\u2014global trends in myopia management attitudes and strategies in clinical practice\u20142022 Update","volume":"64","author":"Wolffsohn","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ajo.2025.06.034_bib0030","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2023-001527","article-title":"Eyecare practitioner perspectives and attitudes towards myopia and myopia management in the UK","volume":"9","author":"Coverdale","year":"2024","journal-title":"BMJ Open Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.06.034_bib0031","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/ICL.0000000000000990","article-title":"Compounded 0.01% atropine\u2014what's in the bottle?","volume":"49","author":"Richdale","year":"2023","journal-title":"Eye Contact Lens"},{"issue":"5","key":"10.1016\/j.ajo.2025.06.034_bib0032","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s40272-024-00642-w","article-title":"Commercial versus compounded preparations in pediatric ophthalmology","volume":"26","author":"Dahlmann-Noor","year":"2024","journal-title":"Paediatr Drugs"},{"issue":"3","key":"10.1016\/j.ajo.2025.06.034_bib0033","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/08164622.2021.1877533","article-title":"Practical use and prescription of ocular medications in children and infants","volume":"104","author":"Webber","year":"2021","journal-title":"Clin Exp Optom"},{"issue":"8","key":"10.1016\/j.ajo.2025.06.034_bib0034","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/jamaophthalmol.2023.2855","article-title":"Low-dose 0.01% atropine eye drops vs placebo for myopia control: a randomized clinical trial","volume":"141","author":"Repka","year":"2023","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajo.2025.06.034_bib0035","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2147\/OPTH.S362342","article-title":"Photorefraction screening plus atropine treatment for myopia is cost-effective: a proof-of-concept Markov analysis","volume":"16","author":"Hong","year":"2022","journal-title":"Clin Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2025.06.034_bib0036","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/archophthalmol.2010.216","article-title":"Current challenges of ophthalmology in France","volume":"128","author":"Audo","year":"2010","journal-title":"Arch Ophthalmol"},{"issue":"20","key":"10.1016\/j.ajo.2025.06.034_bib0037","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1111\/j.1559-1816.1991.tb00497.x","article-title":"Sex differences in stereotypes of spectacles","volume":"21","author":"Harris","year":"1991","journal-title":"J Appl Soc Psychol"},{"issue":"5","key":"10.1016\/j.ajo.2025.06.034_bib0038","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/opo.12080","article-title":"Myopia, contact lens use and self-esteem","volume":"33","author":"Dias","year":"2013","journal-title":"Ophthalmic Physiol Opt"},{"issue":"9","key":"10.1016\/j.ajo.2025.06.034_bib0039","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1136\/bjo.84.9.1031","article-title":"Quality of life in myopia","volume":"84","author":"Rose","year":"2000","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.06.034_bib0040","article-title":"Interventions for myopia control in children: a living systematic review and network meta-analysis","author":"Lawrenson","year":"2023","journal-title":"Cochrane Datab Syst Rev"},{"issue":"2","key":"10.1016\/j.ajo.2025.06.034_bib0041","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/opo.13272","article-title":"Red light instruments for myopia exceed safety limits","volume":"44","author":"Ostrin","year":"2024","journal-title":"Ophthalmic Physiol Opt"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425003368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425003368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:46:24Z","timestamp":1762080384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939425003368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":41,"alternative-id":["S0002939425003368"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2025.06.034","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors Affecting the Lifetime Cost of Myopia and the Impact of Active Myopia Treatments in Europe","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2025.06.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}